Copy Link Print Information

Dioscin

(Synonyms: Collettiside III; CCRIS 4123)
11 Cited Publications
Kundenbewertung

Based on 11 publication(s) in Google Scholar

Dioscin (CCRIS 4123; Collettiside III) is a natural plant-derived steroidal saponin that has good anti-cancer activity against a variety of cancer cells. Dioscin causes DNA damage and induces apoptosis in HeLa and SiHa cells. Dioscin regulates ROS-mediated DNA damage and mitochondrial signaling pathways, exerting anticancer activity.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.95%
  • CAS. Nr.: 19057-60-4
  • Formel: C45H72O16
  • Molecular Weight:869.04
  • Speicherung:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 2 years , -20°C, 1 year
  • Dioscin Chemical Structure
    Dioscin Chemical Structure
  • Experimental Validation Results for Dioscin
  • Experimental Validation Results for Dioscin
  • Experimental Validation Results for Dioscin
  • Experimental Validation Results for Dioscin
  • Experimental Validation Results for Dioscin
  • Experimental Validation Results for Dioscin
  • Experimental Validation Results for Dioscin
  • Experimental Validation Results for Dioscin
CAS. Nr.: 19057-60-4
Größe
Preis
Verfügbarkeit
Menge
Amount: USD 0.00
Please select quantity
or
or

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Dioscin:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Finden Sie Ihren Händler vor Ort Your local distributor: Hycultec GmbHHycultec
  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Dioscin

More
Customer Validation & Images
RT-PCRWBHistological Imaging/StainingIPFlow CytometryIF
  • RT-PCR
  • WB
  • Histological Imaging/Staining
  • IP
  • Flow Cytometry
  • IF
  • WB
  • WB
Keywords
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Einloggen
Registrieren
Sign in to MedChemExpress
Neuen Account Registrieren

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Dioscin Chemical Structure
    Dioscin Chemical Structure
    1/16
  • 1/16

    Dioscin purchased from MedChemExpress. Usage Cited in: J Pharm Anal. 2025 Nov 11.

    Customer Validation
     Dioscin (200 nM, 24 h) alleviates gout by inhibiting hypoxia-inducible factor 1-alpha (HIF-1α) in CD4+ T cells. Quantitative PCR analysis revealing significantly elevated mRNA levels of HIF-1α after DIO treatment (n = 3).

  • 1/16

    Dioscin purchased from MedChemExpress. Usage Cited in: J Pharm Anal. 2025 Nov 11.

    Customer Validation
     Dioscin (200 nM, 24 h) alleviates gout by inhibiting hypoxia-inducible factor 1-alpha (HIF-1α) in CD4+ T cells. Western blot analysis revealing significantly elevated protein levels of HIF-1α after DIO treatment (n = 3).

  • 1/16

    Dioscin purchased from MedChemExpress. Usage Cited in: J Pharm Anal. 2025 Nov 11.

    Customer Validation
     Representative images and hematoxylin and eosin (H&E) analysis of footpads after IOX4 and Dioscin (20 mg/kg, intraperitoneal injection weekly over a six-week period) treatment (n = 3).

  • 1/16

    Dioscin purchased from MedChemExpress. Usage Cited in: J Pharm Anal. 2025 Nov 11.

    Customer Validation
     Pull-down analysis between Dioscin (200 nM, 24 h) and HIF-1α in primary CD4+ T cells (n = 3).

  • 1/16

    Dioscin purchased from MedChemExpress. Usage Cited in: J Pharm Anal. 2025 Nov 11.

    Customer Validation
     Dioscin (20 mg/kg, intraperitoneal injection weekly over a six-week period) reshapes CD4+ T cell differentiation via hypoxia-inducible factor 1-alpha (HIF-1α). T helper 17 (Th17) cell proportions in the blood, intestine, and spleen of DIO-treated urate oxidase (Uox)-knockout (KO) mice (n = 8).

  • 1/16

    Dioscin purchased from MedChemExpress. Usage Cited in: J Pharm Anal. 2025 Nov 11.

    Customer Validation
     Dioscin (20 mg/kg, intraperitoneal injection weekly over a six-week period) reshapes CD4+ T cell differentiation via hypoxia-inducible factor 1-alpha (HIF-1α). Multiplex immunofluorescence staining of Th17 cells in the footpad of DIO-treated Uox-KO mice (n = 3): representative images and quantitative analysis of Th17 cell numbers.

  • 1/16

    Dioscin purchased from MedChemExpress. Usage Cited in: Int Immunopharmacol. 2023 Apr:117:109839. [Abstract]

    Customer Validation
     Dioscin-Medium group (5 mg/kg; p.o.; every-two days for 12 weeks) profoundly inhibits the phosphorylation of NF-ĸB in mice (Fig H and I). Dioscin-Low (Dio-L, 2.5 mg/kg), Dioscin-Medium (Dio-M, 5 mg/kg) and Dioscin-High (Dio-H, 10 mg/Kg).

  • 1/16

    Dioscin purchased from MedChemExpress. Usage Cited in: Mol Med Rep. 2017 Oct;16(4):4922-4926. [Abstract]

    Customer Validation
     Dioscin concentrations of 0.5, 1, 5, 10 and 25 µg/mL promotes the expression of ALP and inhibits the expression of LC3B in MC3T3-E1 cells, in a concentration-dependent manner.

  • Dioscin